Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00668655 · ClinicalTrials.gov registry record
An Evaluation of the Cosmetic Appearance of Metronidazole Gel (MetroGel®) 1%
A clinical trial, sponsored by Galderma R&D.
- Completed
- Registry status
- 30
- Enrollment target
NCT00668655: Completed study, sponsored by Galderma R&D.
NCT00668655 is a clinical trial that has completed, run by Galderma R&D. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00668655 has completed, sponsored by Galderma R&D.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the cosmetic appearance of metronidazole gel (MetroGel®) 1% with commonly marketed facial foundations.
Interventions
- DRUG Metronidazole Gel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2008-02 |
| Est. Completion | 2008-03 |
What the finished NCT00668655 record still lists
NCT00668655 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Metronidazole Gel is the first listed.
NCT00668655 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00668655 about?
NCT00668655 is a clinical study titled "An Evaluation of the Cosmetic Appearance of Metronidazole Gel (MetroGel®) 1%". The purpose of this study is to determine the cosmetic appearance of metronidazole gel (MetroGel®) 1% with commonly marketed facial foundations.
What is the current status of trial NCT00668655?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2008-02. Estimated completion is 2008-03.
What interventions are being tested in trial NCT00668655?
The interventions under investigation include: Metronidazole Gel (DRUG).
Who is sponsoring clinical trial NCT00668655?
This trial is sponsored by Galderma R&D, which has 158 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia